Non-Inferiority Clinical Trials
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 8, 2016
April 27, 2020
c4be9c7c-051a-4a72-8e2e-d996945a9cd9
Related Documents
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product
Guidance DocumentApril 28, 2015Center for Drug Evaluation and Research
Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry
Guidance DocumentDecember 2, 2019Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.